ZEO SCIENTIFIX INC (ZEOX)
ZEOX moved a median of 0.00% 30 minutes after news, and -0.55% by the close. How ZEOX actually reacts to news — the realized, point-in-time move the market made, measured across 151 labeled events over the last three years with zero look-ahead.
ZEOX’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 20% | 141 |
| 30-min | 0.00% | 24% | 141 |
| 60-min | 0.00% | 28% | 141 |
| to close | -0.55% | 37% | 143 |
| Middle 50% of ZEOX reactions | -0.61% to 0.00% |
|---|---|
| Median reaction (30-min) | 0.00% |
| Measured reactions | 151 |
Half of all ZEO SCIENTIFIX INC news events land between -0.61% and +0.00% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when ZEOX moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to ZEOX's baseline. Nothing else.
Recent ZEOX events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Form 10-KT Zeo ScientifiX, Inc. For: Jun 30 | SEC filing · Form 10-KT | SEC EDGAR | +0.00% | -20.35% | |
| Form NT 10-K Zeo ScientifiX, Inc. For: Jun 30 | SEC filing · Form NT | SEC EDGAR | — | — | |
| Form 8-K Zeo ScientifiX, Inc. For: Sep 10 | SEC filing · Form 8-K | SEC EDGAR | — | — | |
| Form 8-K Zeo ScientifiX, Inc. For: Sep 15 | SEC filing · Form 8-K | SEC EDGAR | +3.66% | +3.66% | |
| ZEO ScientifiX Plans Expansion into Georgia and Tennessee as New Regenerative Medicine Laws Take Effect | Press release | ACCESS Newswire | +3.66% | +3.66% | |
| Form NT 10-Q Zeo ScientifiX, Inc. For: Jul 31 | SEC filing · Form NT | SEC EDGAR | +3.66% | +3.66% | |
| Form 8-K Zeo ScientifiX, Inc. For: Sep 01 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -4.00% | |
| ZEO ScientifiX Announces Multidisciplinary Expert Faculty Lineup for the ZEO Xperience | Press release | ACCESS Newswire | +0.00% | -4.00% | |
| Form 8-K Zeo ScientifiX, Inc. For: Aug 04 | SEC filing · Form 8-K | SEC EDGAR | +5.52% | -3.60% | |
| ZEO ScientifiX Launches First-of-Its-Kind ZEO Xperience, a Three-Day Immersive Regenerative Medicine Experience for Healthcare Professionals | Press release | ACCESS Newswire | +5.52% | -3.60% | |
| Form S-8 Zeo ScientifiX, Inc. | SEC filing · Form S-8 | SEC EDGAR | +0.00% | -1.41% | |
| Form 8-K Zeo ScientifiX, Inc. For: Jul 21 | SEC filing · Form 8-K | SEC EDGAR | -3.89% | -6.11% | |
| ZEO ScientifiX Strengthens South Florida's Growing Biotechnology Ecosystem Through Regenerative Medicine Innovation | Press release | ACCESS Newswire | -3.89% | -6.11% | |
| Form 8-K Zeo ScientifiX, Inc. For: Jul 08 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +1.11% | |
| ZEO ScientifiX Reports Strong Revenue Growth for Three Months and Six Months Ended April 30, 2026 | Press release | ACCESS Newswire | +0.00% | +1.11% | |
| Form 8-K Zeo ScientifiX, Inc. For: Jul 01 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -0.56% | |
| ZEO ScientifiX to Host Live Educational Webinar for Healthcare Professionals Exploring the Southeast Regenerative Medicine Revolution | Press release | ACCESS Newswire | +0.00% | -0.56% | |
| Form 8-K Zeo ScientifiX, Inc. For: Jun 16 | SEC filing · Form 8-K | SEC EDGAR | -1.10% | +0.06% | |
| ZEO ScientifiX Donates Products to Support Pediatric Burn Reconstruction Mission in Peru | Press release | ACCESS Newswire | -1.10% | +0.06% | |
| Form 10-Q Zeo ScientifiX, Inc. For: Apr 30 | SEC filing · Form 10-Q | SEC EDGAR | -1.10% | +0.06% | |
| Form 8-K Zeo ScientifiX, Inc. For: Jun 10 | SEC filing · Form 8-K | SEC EDGAR | -1.25% | -1.25% | |
| Form 8-K Zeo ScientifiX, Inc. For: Jun 09 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -10.70% | |
| ZEO ScientifiX Expands Medical Advisory Board with Leaders in Regenerative and Longevity Medicine | Press release | ACCESS Newswire | +0.00% | -10.70% | |
| Form 8-K Zeo ScientifiX, Inc. For: May 27 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +2.78% | |
| ZEO ScientifiX Launches Physician-Led Patient Masterclass Program Following Grassroots Demand in the Southeast | Press release | ACCESS Newswire | +0.00% | +2.78% | |
| Form 8-K Zeo ScientifiX, Inc. For: May 12 | SEC filing · Form 8-K | SEC EDGAR | -2.22% | -5.30% | |
| ZEO ScientifiX Announces That Unaudited Monthly Sales Surpassed $1.0 million in April 2026, the First Time The Company Has Achieved This Milestone. | Press release | ACCESS Newswire | -2.22% | -5.30% | |
| Form 8-K Zeo ScientifiX, Inc. For: Apr 21 | SEC filing · Form 8-K | SEC EDGAR | -0.61% | -2.99% | |
| ZEO ScientifiX Surpasses 500 Physicians Trained in Regenerative Medicine Compliance; Monthly Masterclasses Average 70+ Clinicians | Press release | ACCESS Newswire | -0.61% | -2.99% | |
| Form 8-K Zeo ScientifiX, Inc. For: Apr 09 | SEC filing · Form 8-K | SEC EDGAR | -5.95% | -5.95% | |
| Regen Therapy Partners with Stealth Health to Bring Specialized Telemedicine Services and Longevity Programs to 3,000 Clinics - Powered by an Exclusive Scientific and Biologics Strategic Collaboration with ZEO ScientifiX (OTCQB:ZEOX) | Press release | ACCESS Newswire | -5.95% | -5.95% | |
| Form 8-K Zeo ScientifiX, Inc. For: Apr 07 | SEC filing · Form 8-K | SEC EDGAR | — | +0.00% | |
| ZEO ScientifiX (OTCQB: ZEOX) Selected as Qualified Team Advancing into the XPRIZE Healthspan Semi-Finals Stage | Press release | ACCESS Newswire | — | — | |
| Form 8-K Zeo ScientifiX, Inc. For: Mar 31 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +2.30% | |
| Form 8-K Zeo ScientifiX, Inc. For: Mar 23 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +19.21% | |
| Form 10-Q Zeo ScientifiX, Inc. For: Jan 31 | SEC filing · Form 10-Q | SEC EDGAR | +0.00% | +0.00% | |
| Form 10-K Zeo ScientifiX, Inc. For: Oct 31 | SEC filing · Form 10-K | SEC EDGAR | -0.39% | +3.34% | |
| Form 8-K Zeo ScientifiX, Inc. For: Jan 23 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +1.55% | |
| Form 8-K Zeo ScientifiX, Inc. For: Jan 14 | SEC filing · Form 8-K | SEC EDGAR | +1.32% | +1.32% | |
| Cytora Therapeutics, Made Scientific, and Zeo ScientifiX Announce Partnership to Manufacture and Commercialize Cytora's Allogeneic Stem Cell Therapy in the United States | Press release | PR Newswire | +4.73% | +4.73% | |
| Form 8-K Zeo ScientifiX, Inc. For: Jan 07 | SEC filing · Form 8-K | SEC EDGAR | +4.73% | +4.73% | |
| Form 8-K Zeo ScientifiX, Inc. For: Dec 24 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +1.82% | |
| Form D Zeo ScientifiX, Inc. | SEC filing · Form D | SEC EDGAR | +0.00% | -5.00% | |
| Form 8-K Zeo ScientifiX, Inc. For: Nov 30 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -0.48% | |
| Form 8-K Zeo ScientifiX, Inc. For: Oct 23 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +0.52% | |
| ZEO ScientifiX(TM) Positioned for New Growth as Florida Opens Stem Cell Market | Press release | ACCESS Newswire | +0.00% | +0.52% | |
| Form 10-Q Zeo ScientifiX, Inc. For: Jul 31 | SEC filing · Form 10-Q | SEC EDGAR | — | — | |
| Form 8-K Zeo ScientifiX, Inc. For: Jul 25 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -0.55% | |
| Form 8-K Zeo ScientifiX, Inc. For: Jul 18 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -7.27% | |
| Form 8-K Zeo ScientifiX, Inc. For: Jul 09 | SEC filing · Form 8-K | SEC EDGAR | +2.96% | +2.96% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the ZEOX section they belong to.
Where else ZEOX is measured.
ZEOX earnings → · Analyst actions → · SEC filings →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is ZEO SCIENTIFIX INC's median reaction calculated?
Every labeled ZEOX news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 151 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 24% of ZEOX's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does ZEOX's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.